REGENERON PHARMACEUTICALS, INC. Diversified Active

Location: Tarrytown, NY

CIK: 0000872589 · Show all filings

Period: Q4 2024 (Next →)

Filing Date: Feb 7, 2025

Total Value: $1.095B (100.0% shares, 0.0% debt)

Holdings (6)

ALNY Alnylam Pharmaceuticals, Inc. 95.5%

Value $1.046B Shares 4,444,445 Est. Cost $262.99 Unrealized 0.0%

NTLA Intellia Therapeutics, Inc. 3.9%

Value $43.18M Shares 3,702,995 Est. Cost $15.61 Unrealized 0.0%

— 2seventy bio, Inc. 0.3%

Value $3.689M Shares 1,254,827 Est. Cost $2.94 Unrealized —

— Adicet Bio, Inc. 0.1%

Value $931K Shares 968,183 Est. Cost $0.96 Unrealized —

— Adverum Biotechnologies, Inc. 0.1%

Value $845K Shares 180,909 Est. Cost $4.67 Unrealized —

— bluebird bio, Inc. 0.0%

Value $175K Shares 21,000 Est. Cost $8.34 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
ALNY	Alnylam Pharmaceuticals, Inc.	4,444,445	$1.046B	95.5%	$262.99	0.0%	Common Stock	02043Q107
NTLA	Intellia Therapeutics, Inc.	3,702,995	$43.18M	3.9%	$15.61	0.0%	Common Stock	45826J105
—	2seventy bio, Inc.	1,254,827	$3.689M	0.3%	$2.94	—	Common Stock	901384107
—	Adicet Bio, Inc.	968,183	$931K	0.1%	$0.96	—	Common Stock	007002108
—	Adverum Biotechnologies, Inc.	180,909	$845K	0.1%	$4.67	—	Common Stock	00773U207
—	bluebird bio, Inc.	21,000	$175K	0.0%	$8.34	—	Common Stock	09609G209